Acal plc’s (ACL) “Buy” Rating Reaffirmed at Peel Hunt

Acal plc (LON:ACL)‘s stock had its “buy” rating reaffirmed by research analysts at Peel Hunt in a research report issued on Tuesday. They presently have a GBX 360 ($4.69) price objective on the stock. Peel Hunt’s price objective suggests a potential upside of 20.00% from the stock’s previous close.

A number of other research firms have also recently issued reports on ACL. FinnCap reiterated a “buy” rating and set a GBX 339 ($4.42) target price on shares of Acal plc in a report on Tuesday. Numis Securities Ltd restated a “buy” rating and issued a GBX 305 ($3.97) price objective on shares of Acal plc in a report on Thursday, April 20th.

Shares of Acal plc (LON:ACL) opened at 309.00 on Tuesday. The firm has a 50 day moving average price of GBX 294.64 and a 200-day moving average price of GBX 252.81. The firm’s market cap is GBX 194.82 million. Acal plc has a 12 month low of GBX 203.20 and a 12 month high of GBX 309.00.

ILLEGAL ACTIVITY NOTICE: This report was first posted by [[site]] and is owned by of [[site]]. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at [[permalink]].

About Acal plc

ACAL plc designs, manufactures and distributes electronic products and solutions. The Company operates through two segments: Custom Distribution and Design & Manufacturing. The Custom Distribution segment provides customized electronic, photonic and medical products to the industrial, medical and healthcare markets, both from a range of international suppliers and from the Company’s Design & Manufacturing division.